112 related articles for article (PubMed ID: 33485459)
1. Evidence-based benchmarks for use of cancer surgery in high-income countries: a population-based analysis.
Perera SK; Jacob S; Sullivan R; Barton M
Lancet Oncol; 2021 Feb; 22(2):173-181. PubMed ID: 33485459
[TBL] [Abstract][Full Text] [Related]
2. Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study.
Perera SK; Jacob S; Wilson BE; Ferlay J; Bray F; Sullivan R; Barton M
Lancet Oncol; 2021 Feb; 22(2):182-189. PubMed ID: 33485458
[TBL] [Abstract][Full Text] [Related]
3. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
[TBL] [Abstract][Full Text] [Related]
4. Estimation of an optimal chemotherapy utilisation rate for cancer: setting an evidence-based benchmark for quality cancer care.
Jacob SA; Ng WL; Do V
Clin Oncol (R Coll Radiol); 2015 Feb; 27(2):77-82. PubMed ID: 25455844
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
Soerjomataram I; Cabasag C; Bardot A; Fidler-Benaoudia MM; Miranda-Filho A; Ferlay J; Parkin DM; Ranganathan R; Piñeros M; Znaor A; Mery L; Joko-Fru YW; Dikshit R; Sankaranarayanan R; Swaminathan R; Bray F;
Lancet Oncol; 2023 Jan; 24(1):22-32. PubMed ID: 36603919
[TBL] [Abstract][Full Text] [Related]
7. Improving Global Surgical Oncology Benchmarks: Defining the Unmet Need for Cancer Surgery in Ghana.
Gaskill CE; Gyedu A; Stewart B; Quansah R; Donkor P; Mock C
World J Surg; 2021 Sep; 45(9):2661-2669. PubMed ID: 34152449
[TBL] [Abstract][Full Text] [Related]
8. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
[TBL] [Abstract][Full Text] [Related]
9. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
Ward ZJ; Scott AM; Hricak H; Abdel-Wahab M; Paez D; Lette MM; Vargas HA; Kingham TP; Atun R
Lancet Oncol; 2020 Aug; 21(8):1077-1088. PubMed ID: 32758462
[TBL] [Abstract][Full Text] [Related]
10. Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
Rutherford MJ; Arnold M; Bardot A; Ferlay J; De P; Tervonen H; Little A; Bucher O; St Jacques N; Gavin A; Engholm G; Møller B; O'Connell DL; Merrett N; Parkin DM; Bray F; Soerjomataram I
Int J Cancer; 2021 Dec; 149(12):2020-2031. PubMed ID: 34460109
[TBL] [Abstract][Full Text] [Related]
11. Unemployment risk and income change after testicular cancer diagnosis: A population-based study.
Rottenberg Y; Ratzon NZ; Jacobs JM; Cohen M; Peretz T; de Boer AG
Urol Oncol; 2016 Jan; 34(1):5.e27-33. PubMed ID: 26427695
[TBL] [Abstract][Full Text] [Related]
12. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
13. Defining the need for radiotherapy for lung cancer in the general population: a criterion-based, benchmarking approach.
Barbera L; Zhang-Salomons J; Huang J; Tyldesley S; Mackillop W
Med Care; 2003 Sep; 41(9):1074-85. PubMed ID: 12972847
[TBL] [Abstract][Full Text] [Related]
14. Benchmarking Global Trauma Care: Defining the Unmet Need for Trauma Surgery in Ghana.
Gyedu A; Stewart B; Gaskill C; Donkor P; Quansah R; Mock C
J Surg Res; 2020 Mar; 247():280-286. PubMed ID: 31690530
[TBL] [Abstract][Full Text] [Related]
15. Testicular cancer: a narrative review of the role of socioeconomic position from risk to survivorship.
Richardson LC; Neri AJ; Tai E; Glenn JD
Urol Oncol; 2012; 30(1):95-101. PubMed ID: 22127018
[TBL] [Abstract][Full Text] [Related]
16. Improving Benchmarks for Global Surgery: Nationwide Enumeration of Operations Performed in Ghana.
Gyedu A; Stewart B; Gaskill C; Boakye G; Appiah-Denkyira E; Donkor P; Maier R; Quansah R; Mock C
Ann Surg; 2018 Aug; 268(2):282-288. PubMed ID: 28806300
[TBL] [Abstract][Full Text] [Related]
17. Deriving literature-based benchmarks for pediatric appendectomy and cholecystectomy complications from national databases in high-income countries: A systematic review and meta-analysis.
Daodu OO; Zondervan N; Urban D; MacRobie A; Brindle M
J Pediatr Surg; 2019 Dec; 54(12):2528-2538. PubMed ID: 31575414
[TBL] [Abstract][Full Text] [Related]
18. Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer.
Fong A; Ng W; Barton MB; Delaney GP
Breast; 2010 Oct; 19(5):345-9. PubMed ID: 20223666
[TBL] [Abstract][Full Text] [Related]
19. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
